CV Sciences, Inc. – OTC:CVSI
CV Sciences stock price today
$0.039
+0.00
+9.15%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 18 hours
CV Sciences stock price monthly change
-21.91%
month
CV Sciences stock price quarterly change
-21.91%
quarter
CV Sciences stock price yearly change
-2.70%
year
CV Sciences key metrics
Market Cap | 6.82M |
Enterprise value | 6.39M |
P/E | -0.69 |
EV/Sales | 0.39 |
EV/EBITDA | -0.96 |
Price/Sales | 0.41 |
Price/Book | -8.61 |
PEG ratio | -0.01 |
EPS | -0.02 |
Revenue | 15.85M |
EBITDA | -2.43M |
Income | -3.23M |
Revenue Q/Q | -3.51% |
Revenue Y/Y | -0.30% |
Profit margin | -56.37% |
Oper. margin | -42.25% |
Gross margin | 34.25% |
EBIT margin | -42.25% |
EBITDA margin | -15.34% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCV Sciences stock price history
CV Sciences stock forecast
CV Sciences financial statements
| Jun 2023 | 3.96M | -1.28M | -32.48% |
|---|---|---|---|
| Sep 2023 | 4.08M | -447K | -10.93% |
| Dec 2023 | 3.80M | -869K | -22.86% |
| Mar 2024 | 4.00M | -628K | -15.69% |
| Jun 2023 | 9879000 | 5.98M | 60.58% |
|---|---|---|---|
| Sep 2023 | 9643000 | 6.16M | 63.92% |
| Dec 2023 | 26346000 | 23.44M | 88.98% |
| Mar 2024 | 8466000 | 6.10M | 72.1% |
| Jun 2023 | 1.41M | 0 | -435K |
|---|---|---|---|
| Sep 2023 | -19K | 0 | -28K |
| Dec 2023 | -114K | -156K | -56K |
| Mar 2024 | -518K | 0 | -136K |
CV Sciences alternative data
| Aug 2023 | 42 |
|---|---|
| Sep 2023 | 42 |
| Oct 2023 | 42 |
| Nov 2023 | 42 |
| Dec 2023 | 42 |
| Jan 2024 | 42 |
| Feb 2024 | 42 |
| Mar 2024 | 42 |
| Apr 2024 | 42 |
| May 2024 | 42 |
| Jun 2024 | 42 |
| Jul 2024 | 42 |
CV Sciences other data
0.00%
0.00%
of CVSI is owned by hedge funds
5.1K
+5K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2020 | 0 | 8803 |
| Jul 2020 | 0 | 108535 |
| Nov 2020 | 0 | 400000 |
| Dec 2020 | 0 | 100200 |
| Jan 2021 | 0 | 366740 |
| May 2021 | 50000 | 0 |
| Quarter | Transcript |
|---|---|
| Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Joseph D. Dowling (1957) Chief Executive Officer, Sec. & Director | $378,600 |
| Mr. Joerg Grasser (1975) Chief Financial Officer | $214,710 |
-
What's the price of CV Sciences stock today?
One share of CV Sciences stock can currently be purchased for approximately $0.04.
-
When is CV Sciences's next earnings date?
Unfortunately, CV Sciences's (CVSI) next earnings date is currently unknown.
-
Does CV Sciences pay dividends?
No, CV Sciences does not pay dividends.
-
How much money does CV Sciences make?
CV Sciences has a market capitalization of 6.82M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1.24% to 16M US dollars.
-
What is CV Sciences's stock symbol?
CV Sciences, Inc. is traded on the OTC under the ticker symbol "CVSI".
-
What is CV Sciences's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of CV Sciences?
Shares of CV Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are CV Sciences's key executives?
CV Sciences's management team includes the following people:
- Mr. Joseph D. Dowling Chief Executive Officer, Sec. & Director(age: 68, pay: $378,600)
- Mr. Joerg Grasser Chief Financial Officer(age: 50, pay: $214,710)
-
How many employees does CV Sciences have?
As Jul 2024, CV Sciences employs 42 workers.
-
When CV Sciences went public?
CV Sciences, Inc. is publicly traded company for more then 13 years since IPO on 9 Nov 2011.
-
What is CV Sciences's official website?
The official website for CV Sciences is cvsciences.com.
-
Where are CV Sciences's headquarters?
CV Sciences is headquartered at 10070 Barnes Canyon Road, San Diego, CA.
-
How can i contact CV Sciences?
CV Sciences's mailing address is 10070 Barnes Canyon Road, San Diego, CA and company can be reached via phone at +86 62902157.
CV Sciences company profile:
CV Sciences, Inc.
cvsciences.comExchange:
OTC
Full time employees:
69
Industry:
Drug Manufacturers—Specialty & Generic
Sector:
Healthcare
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect distributors, brick and mortar retailers, and select e-tailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. This segment is developing drug candidate CVSI-007 that combines CBD and nicotine in treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
10070 Barnes Canyon Road
San Diego, CA 92121
San Diego, CA 92121
CIK: 0001510964
ISIN: US1266541028
CUSIP: 126654102
